In this study, we have identified miR-23b as a negative regulator of Sp1 expression and provided evidence of the tumor suppressor role of miR-23b, and its downregulation as a consequence of epigenetic mechanisms, supporting the existence of a novel feed-forward loop with a critical growth and survival role in MM and WM. This evidence concerns the gene SP1 and Miyoshi myopathy.